Tetanus Trials in Marietta, United States
Conditions / Tetanus / Marietta, United States
Research into Tetanus spans multiple therapeutic approaches and trial phases.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00258895 | Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL® | COMPLETED | PHASE3 |
| NCT00467519 | Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age | COMPLETED | PHASE3 |
| NCT01311557 | Study of Adacel® Vaccine Administered to Persons 10 Years of Age | COMPLETED | PHASE4 |
| NCT00282295 | US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease | COMPLETED | PHASE4 |
| NCT01346293 | Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age | COMPLETED | PHASE3 |
| NCT00855855 | Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease | COMPLETED | — |
| NCT00777257 | Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine | COMPLETED | PHASE4 |
| NCT01659996 | Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age | COMPLETED | PHASE4 |
| NCT01439165 | Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose | COMPLETED | PHASE4 |
| NCT02096263 | Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants | COMPLETED | PHASE3 |